Revium Rx. (RVRC) — S-1/A Filings
All S-1/A filings from Revium Rx.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
Revium Rx. Launches Dual Offering: IPO at $3.20, Resale at $1.00
— Dec 12, 2025 Risk: high
Revium Rx. (RVRC) filed an S-1/A on December 12, 2025, detailing a self-underwritten initial public offering (IPO) of up to 1,562,500 Units at a fixed price of -
Revium Rx. Launches Dual IPO, Resale Offerings Amid Price Disparity
— Oct 3, 2025 Risk: high
Revium Rx. (RVRC) filed an S-1/A on October 3, 2025, detailing a dual offering strategy: a self-underwritten initial public offering (Primary Offering) of up to -
Revium Rx Launches IPO, Selling Stockholders Eye Massive Resale
— Aug 13, 2025 Risk: high
Revium Rx (RVRC) filed an S-1/A on August 13, 2025, for a self-underwritten initial public offering of up to 1,562,500 Units at a fixed price of $3.20 per Unit.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX